Table 5.
Percentage viability assessment of cells treated with both regular and strontium-doped nanohydroxyapatite pastes done at different dilutions
Sample concentration (µg/mL) | OD value I | OD value II | OD value III | Average OD | Percentage viability |
---|---|---|---|---|---|
Control (untreated cells) | 0.5535 | 0.6474 | 0.5508 | 0.5839 | 100.00 |
Sample code: Regular paste | |||||
6.25 | 0.5415 | 0.5436 | 0.5442 | 0.5431 | 93.01 |
12.5 | 0.5258 | 0.5289 | 0.5273 | 0.5273 | 90.31 |
25 | 0.4621 | 0.4537 | 0.4604 | 0.4587 | 78.56 |
50 | 0.4408 | 0.4315 | 0.4326 | 0.4350 | 74.49 |
100 | 0.4281 | 0.4257 | 0.4174 | 0.4237 | 72.57 |
Sample concentration (µg/mL) | OD value I | OD value II | OD value III | Average OD | Percentage viability |
Control (untreated cells) | 0.6124 | 0.6307 | 0.6202 | 0.6211 | 100.00 |
Sample code: SrnHAp paste | |||||
6.25 | 0.603 | 0.5962 | 0.6132 | 0.6041 | 97.27 |
12.5 | 0.5791 | 0.5845 | 0.5507 | 0.5714 | 92.00 |
25 | 0.4892 | 0.5026 | 0.5142 | 0.5020 | 80.82 |
50 | 0.4522 | 0.4909 | 0.4977 | 0.4803 | 77.33 |
100 | 0.4421 | 0.4804 | 0.4752 | 0.4659 | 75.01 |
Cytotoxic evaluation: The percentage of growth inhibition was calculated using the formula: . OD: Optical density, SrnHAp: Strontium doped nanohydroxyapatite